{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:20:10Z","timestamp":1777512010564,"version":"3.51.4"},"reference-count":32,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"unspecified","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2021,4,4]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Hypoglycemia in type 2 diabetes (T2D) may increase risk for Alzheimer\u2019s disease (AD), but no data on changes in AD-related proteins with differing degrees of hypoglycemia exist. We hypothesized that milder prolonged hypoglycemia would cause greater AD-related protein changes versus severe transient hypoglycemia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research design and methods<\/jats:title>\n                  <jats:p>Two prospective case-control induced hypoglycemia studies were compared: study 1, hypoglycemic clamp to 2.8\u2009mmol\/L (50\u2009mg\/dL) for 1\u2009hour in 17 subjects (T2D (n=10), controls (n=7)); study 2, hypoglycemic clamp to 2.0\u2009mmol\/L (36\u2009mg\/dL) undertaken transiently and reversed in 46 subjects (T2D (n=23), controls (n=23)). Blood sampling at baseline, hypoglycemia and 24-hour post-hypoglycemia, with proteomic analysis of amyloid-related proteins performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In control subjects, the percentage change from baseline to hypoglycemia differed between study 1 and study 2 for 5 of 11 proteins in the AD-related panel: serum amyloid A1 (SAA1) (p=0.009), pappalysin (PAPPA) (p=0.002), apolipoprotein E2 (p=0.02), apolipoprotein E3 (p=0.03) and apolipoprotein E4 (p=0.02). In controls, the percentage change from baseline to 24 hours differed between studies for two proteins: SAA1 (p=0.003) and PAPPA (p=0.004); however, after Bonferroni correction only SAA1 and PAPPA remain significant. In T2D, there were no differential protein changes between the studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The differential changes in AD-related proteins were seen only in control subjects in response to iatrogenic induction of hypoglycemic insults of differing length and severity and may reflect a protective response that was absent in subjects with T2D. Milder prolonged hypoglycemia caused greater AD-related protein changes than severe acute hypoglycemia in control subjects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration numbers<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT02205996\">NCT02205996<\/jats:ext-link>, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03102801\">NCT03102801<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjdrc-2021-002211","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T11:26:20Z","timestamp":1619781980000},"page":"e002211","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Amyloid-related protein changes associated with dementia differ according to severity of hypoglycemia"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct02205996","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03102801","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Abu Saleh Md","family":"Moin","sequence":"first","affiliation":[{"name":"Diabetes Research Center, Qatar Biomedical Research Institute, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Kahal","sequence":"additional","affiliation":[{"name":"Diabetes and Metabolism, Hull York Medical School, Hull, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Al-Qaissi","sequence":"additional","affiliation":[{"name":"Diabetes and Metabolism, Hull York Medical School, Hull, UK"},{"name":"Diabetes and Metabolism, Leeds Medical School, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitya","family":"Kumar","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons in Ireland and Medical University of Bahrain, Busaiteen, Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[{"name":"Diabetes and Metabolism, Hull York Medical School, Hull, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L","family":"Atkin","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons in Ireland and Medical University of Bahrain, Busaiteen, Bahrain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5762-3917","authenticated-orcid":false,"given":"Alexandra E","family":"Butler","sequence":"additional","affiliation":[{"name":"Diabetes Research Center, Qatar Biomedical Research Institute, Doha, Qatar"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"key":"2025073112263686000_9.1.e002211.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.228"},{"key":"2025073112263686000_9.1.e002211.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)70284-2"},{"key":"2025073112263686000_9.1.e002211.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-0023-4"},{"key":"2025073112263686000_9.1.e002211.4","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12087"},{"key":"2025073112263686000_9.1.e002211.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.02.001"},{"key":"2025073112263686000_9.1.e002211.6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.9.1937"},{"key":"2025073112263686000_9.1.e002211.7","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2010.130"},{"key":"2025073112263686000_9.1.e002211.8","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws387"},{"key":"2025073112263686000_9.1.e002211.9","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2019.103995","article-title":"Elevation of plasma soluble amyloid precursor protein beta in Alzheimer's disease","volume":"87","author":"Yun","year":"2020","journal-title":"Arch Gerontol Geriatr"},{"key":"2025073112263686000_9.1.e002211.10","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(92)90039-3"},{"key":"2025073112263686000_9.1.e002211.11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.diabres.2016.09.027","article-title":"Hypoglycemia is associated with dementia in elderly patients with type 2 diabetes mellitus: an analysis based on the Korea national diabetes program cohort","volume":"122","author":"Chin","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"2025073112263686000_9.1.e002211.12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/dom.13548","article-title":"Effects of acute insulin-induced hypoglycaemia on endothelial microparticles in adults with and without type 2 diabetes","volume":"21","author":"Al-Qaissi","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"2025073112263686000_9.1.e002211.13","doi-asserted-by":"crossref","first-page":"338-349","DOI":"10.1111\/dom.14220","article-title":"Hypoglycaemia in type 2 diabetes exacerbates amyloid-related proteins associated with dementia","volume":"23","author":"Moin","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"2025073112263686000_9.1.e002211.14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-61531-z","article-title":"Effect of induced hypoglycemia on inflammation and oxidative stress in type 2 diabetes and control subjects","volume":"10","author":"Kahal","year":"2020","journal-title":"Sci Rep"},{"key":"2025073112263686000_9.1.e002211.15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026332"},{"key":"2025073112263686000_9.1.e002211.16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14357"},{"key":"2025073112263686000_9.1.e002211.17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007"},{"key":"2025073112263686000_9.1.e002211.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(01)00297-2"},{"key":"2025073112263686000_9.1.e002211.19","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12459"},{"key":"2025073112263686000_9.1.e002211.20","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2017.28"},{"key":"2025073112263686000_9.1.e002211.21","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-200001000-00012"},{"key":"2025073112263686000_9.1.e002211.22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00843","article-title":"Serum amyloid A1 (SAA1) revisited: restricted leukocyte-activating properties of homogeneous SAA1","volume":"11","author":"Abouelasrar Salama","year":"2020","journal-title":"Front Immunol"},{"key":"2025073112263686000_9.1.e002211.23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187364","article-title":"Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer's disease patients","volume":"12","author":"Mihel\u010di\u0107","year":"2017","journal-title":"PLoS One"},{"key":"2025073112263686000_9.1.e002211.24","first-page":"395","article-title":"Elevated serum levels of pregnancy-associated plasma protein-A in type 2 diabetics compared to healthy controls: associations with subclinical atherosclerosis parameters","volume":"53","author":"Heidari","year":"2015","journal-title":"Acta Med Iran"},{"key":"2025073112263686000_9.1.e002211.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2010.03830.x"},{"key":"2025073112263686000_9.1.e002211.26","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200201000-00013"},{"key":"2025073112263686000_9.1.e002211.27","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.156257"},{"key":"2025073112263686000_9.1.e002211.28","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.1.2.226"},{"key":"2025073112263686000_9.1.e002211.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(97)13394-8"},{"key":"2025073112263686000_9.1.e002211.30","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2000.102"},{"key":"2025073112263686000_9.1.e002211.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(98)00889-1"},{"key":"2025073112263686000_9.1.e002211.32","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/296069"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2021-002211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:26:42Z","timestamp":1753990002000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2021-002211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,4,30]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bmjdrc-2021-002211"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2021-002211","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}